Five patients seen during a two-month period who developed untoward systemic reactions following high dose intravenous administration of nafcillin are described. Recovery was complete upon discontinuation of the drug. The clustering of these cases and the high incidence (5 of 5) of side effects are highly unusual, and suggest that the frequency of nafcillin reactions might be higher than previously suspected.
It is assumed that all penicillinase-resistant semi-synthetic penicillins are equally effective in treating infections caused by Staphylococcus aureus [ 1, 2] . Little is known, however, about the relative toxicities of these antibiotics. Of the major side effects, rash, urticaria, fever, allergic interstitial nephritis, hepatic toxicity, and hematologic toxicity in the form of reversible granulocytopenia have been commented upon in the literature [3] [4] [5] [6] [7] [8] [9] [10] .
Nafcillin, 6 -(2-ethoxy-l-naphthalmido) penicillanic acid, has been preferred by some clinicians over methicillin and oxacillin, because its use may be associated with a lower incidence of side effects, particularly nephropathy [11] . Furthermore, in one study nafcillin offered better synergistic activity than other penicillinase-resistant penicillins with an aminoglycoside when tested against the enterococci [12] .
This report describes an unusually high occurrence of untoward reactions due to nafcillin observed by us at Yale-New Haven Hospital. During the months of July and August of 1976, five patients, four of whom were seen and followed by the Infectious Disease Section, received high dose intravenous nafcillin for proven or presumed staphylococcal infections. All five subsequently developed various drug reactions, necessitating discontinuation of nafcillin in four of the patients. To the best of our knowledge, no other patient received nafcillin at our institution during this period. 1 1 ,000/mm3, with 76% segmented neutrophils, 2% bands, 14% lymphocytes, 6% monocytes, and 1% eosinophils. The remainder of laboratory exams were.within normal limits. Surgical exploration confirmed the diagnosis of osteomyelitis. All of the bone cultures and one blood culture yielded S. aureus. Post operatively, therapy with intravenous nafcillin, 2 g every 6 hours, was started. On the eighth day of nafcillin therapy a pruritic, maculopapular rash appeared on the abdomen and chest, and rapidly involved the extremities. The WBC count was 12,800/mm3, with 74% neutrophils, 13% lymphocytes, 6% monocytes, and 7% eosinophils. All other laboratory results, including the urinalysis, BUN, and liver function tests were normal. Nafcillin was stopped, and the rash and eosinophilia improved during the subsequent 3 days. None of the patient's other medications were stopped. Therapy with intravenous cephalothin, 2 g every 6 hours was then started, and continued for a total of 30 days. At the time of discharge, the erythrocyte sedimentation was normal, and the WBC count was 8,600/mm3, with 70% neutrophils, 5% bands, 16% lymphocytes, 6% monocytes, 2% basophils, and 1% eosinophils.
CASE REPORTS

Case 5
A 60-year-old male was admitted to Yale-New Haven Hospital after he fell and sustained a fracture of the mid-shaft of the left femur. On admission, physical exam was negative, except for a BP of 152/94 mm Hg, and the pertinent findings associated with the femoral fracture. The admission laboratory data revealed a hemoglobin of 14.6 g/dl, a hematocrit of 43.3%, and a WBC count of 8,800/mm3, with 71% neutrophils, 4% bands, 19% lymphocytes and 6% monocytes. Hydrochlorathiazide, 25 mg/day, was given for hypertension, but stopped after 2 weeks. Treatment with traction was employed initially, and 3 weeks after the admission he underwent internal fixation of the left femur with placement of a Kuntschner rod. Perioperative cephalothin, 1 g every 4 hours, was given for a total of 10 doses. On the twelfth postoperative day the patient developed fever of 1020F, and evidence of the surgical wound infection. Wound cultures yielded an abundant growth of S. aureus. Treatment with intravenous cephalothin was restarted. After two days this was changed to oxacillin and subsequently to intravenous nafcillin, at a dosage of 2 g every 6 hours. In addition, surgical debridement of the wound was carried on. He responded well to the treatment, with gradual clearing of the wound infection. However, CBC's on the thirteenth to sixteenth day of nafcillin therapy showed a persistent eosinophilia of 11%. There was no rash, fever, renal or hepatic abnormalities. Nafcillin was stopped after 21 days of therapy, and the patient was discharged on oral dicoloxacillin 500 mg, four times/ day. The only other medications that the patient had received within one week of development of the eosinophilia were meperidin, flurazepam, and hydroxyzine. No further follow-up blood counts were available at the time of preparation of this manuscript.
DISCUSSION
Adverse reactions to nafcillin have been infrequently reported in the past. Bone marrow examination in two previous case studies of nafcillin-induced granulocytopenia demonstrated a maturation arrest of the myeloid series at the myelocyte stage, without depression of the erythroid or the megkaryocytic series [9, 10] . Nafcillin has also been reported to cause interstitial nephritis in a patient with a previous history of methicillin-induced nephropathy [8] . In a recent study comparing nafcillin and methicillin in treatment of patients with serious staphylococcal infections, nafacillin was associated with a substantially lower incidence of side effects. In particular, no instances of nephropathy were observed in the 29 patients treated with nafcillin, and only four patients developed reactions to the drug. One patient had only fever and rash, two developed granulocytopenia, and one patient treated with the highest daily dose of nafcillin (12 grams) developed granulocytopenia associated with fever and rash [11] . In contrast, in another as yet not completed study comparing nafcillin versus combination of nafcillin and gentamicin in treatment of severe staphylococcal infections, reaction rates (eosinophilia, rash, and neutropenia) of over 50% have been observed with combined regimen. Nafcillin alone has been associated with adverse reactions in nearly 30% of cases (Merle Sande, M.D., personal communication). In our series of five patients receiving intravenous nafcillin, all five developed untoward reactions. Eosinophilia was seen in all, and maculopapular rash in four patients. Two had both fever and a reversible granulocytopenia. No evidence of nephropathy or liver damage was observed in any of the patients (Refer to Table 1 .) All of the four patients who had adequate follow-up experienced complete recovery upon discontinuation of nafcillin, and did not exhibit cross-reactive side effects with cephalosporins as the substitute therapy. None of our patients had a past history of allergic reactions to the penicillins or other drugs. The nafcillin used during this period came from different lots, was freshly prepared, and administered by the standard "piggy back" intravenous infusion in isotonic saline, or 5% dextrose solution. Thus the possibility that the reactions were due to the contamination of a single lot of the drug is unlikely. Furthrermore the concurrent use of other medications in these patients was minimal, and none were stopped when the adverse reactions appeared.
Fever, rash, and pruritus occurring on penicillin therapy have been attributed to hypersensitivity reactions. Likewise, the interstitial nephritis due to penicillin and its homologues (including nafcillin) is thought to represent a dose-related hypersensitivity reaction [8, 13] . One group of investigators demonstrated antitubular basement membrane antibodies in methicillin-associated nephritis [14] . The mechanism of selective granulocytopenia by penicillin homologues has been the source of considerable speculation. Most patients, as did ours, appear to develop this complication at about 3 weeks into treatment by these agents [7, [9] [10] [11] . Both a direct toxic effect on the granulocytic series [15] , and an antibody-mediated hypersensitivity reaction [7, 9] have been suggested. In a recent study [16] antineutrophil antibodies were demonstrated in the sera of 2 patients with nafcillin, and one patient with oxacillin-induced granulocytopenia. The authors suggested that these drugs attach to the cell surface where they function as haptens, with subsequent antibody attachment. The opsonized neutrophils are then sequestered and phagocytized by macrophages of the reticuloendothelial organs. The association of eosinophilia and rash observed in our patients with granulocytopenia favors a hypersensitivity reaction. However, further studies are needed to elucidate the mechanism(s) of granulocytopenia due to penicillin homologues.
These cases are brought to the attention of readers to emphasize the possibility that when larger series of patients are treated with nafcillin, reaction rates will approach those reported with other semi-synthetic, penicillinase-resistant penicillins. Careful observation of patients receiving large doses of intravenous nafcillin (or other penicillinase-resistant penicillins) for the development of hypersensitivity reactions, and frequent monitoring of blood counts with differentials, as well as renal and hepatic functions are recommended, particularly after 2 weeks of treatment. If isolated neutropenia (neutrophil count < 1,800/mm3) appears without other manifestations of hypersensitivity then the dose should be lowered and the patient followed closely for other complications. Should these appear at any time or the granulocyte count fall below 1,000/ mm3 the drug should be stopped. Vancomycin or a cephalosporin may provide suitable alternative treatment for staphylococcal infections should such side effects be observed.
